Cethromycin: a new ketolide antibiotic.

CONCLUSIONS: Cethromycin appears to be a promising ketolide for the treatment of mild to moderate community-acquired pneumonia. It was denied approval by the FDA in 2009 pending more evidence to show its efficacy, with more recent studies showing its noninferiority to antibiotics for the same indication.
PMID: 23463743 [PubMed - in process]

Source: The Annals of Pharmacotherapy - March 1, 2013 Category: Drugs & Pharmacology Authors: Mansour H, Chahine EB, Karaoui LR, El-Lababidi RM Tags: Ann Pharmacother Source Type: research